Dan Leonard
Stock Analyst at UBS
(1.59)
# 1562
Out of 5,370 analysts
287
Total ratings
52.38%
Success rate
9.77%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MTD Mettler-Toledo Intl | Upgrades: Buy | 1530 1350 | 1182.83 | 14.13% | 9 | May 20, 2025 | |
TXG 10x Genomics | Maintains: Neutral | 14 12 | 11.03 | 8.79% | 5 | May 13, 2025 | |
TECH Bio-Techne | Maintains: Buy | 95 70 | 51.56 | 35.76% | 11 | May 9, 2025 | |
BRKR Bruker | Maintains: Neutral | 57 45 | 39.02 | 15.33% | 11 | May 8, 2025 | |
IQV IQVIA Hldgs | Maintains: Buy | 255 185 | 159.4 | 16.06% | 14 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 355 310 | 231.74 | 33.77% | 20 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 65 70 | 49.13 | 42.48% | 9 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 145 115 | 96.31 | 19.41% | 2 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 715 500 | 404.82 | 23.51% | 15 | Apr 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 275 240 | 200.98 | 19.41% | 14 | Apr 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 29 25 | 13.43 | 86.15% | 7 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 250 185 | 151.28 | 22.29% | 6 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 9 | 6.91 | 30.25% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 420 350 | 300.75 | 16.38% | 1 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 16 16 | 10.76 | 48.7% | 9 | Sep 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 35 | 20.92 | 67.3% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 160 150 | 119.07 | 25.98% | 20 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 225 200 | 90.09 | 122% | 16 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 11 | 2.15 | 411.63% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 70 | 168.2 | -58.38% | 7 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 75 90 | 53.29 | 68.89% | 9 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Underperform | 7 | 10.26 | -31.77% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 160 | n/a | n/a | 12 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 345 | 347.88 | -0.83% | 12 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 260 | 146.97 | 76.91% | 5 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Underperform | 1 | n/a | n/a | 3 | Aug 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 160 145 | 182.06 | -20.36% | 10 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 95 90 | 65.16 | 38.12% | 12 | Feb 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 62 64 | 47.42 | 34.23% | 2 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 330 340 | 263.67 | 28.95% | 11 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 24 | 24.05 | -0.21% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 4 2 | n/a | n/a | 3 | May 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 45 35 | 4.92 | 611.38% | 11 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 80 55 | n/a | n/a | 3 | May 30, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Hold | 18 0 | n/a | n/a | 3 | May 7, 2018 |